Abstract
The aim of the present study was to investigate the efficacy of probiotic yoghurt Lactobacillus rhamnosus GG (LGG) in the treatment of Irritable bowel syndrome (IBS). Eighty-three IBS patients yielded data to be analysed from this 9-week, placebo-controlled, double-blind and randomized trial. The patients consumed either a LGG-containing probiotic yoghurt (treatment group; n = 44) or a placebo (n = 39) twice daily for 6 weeks. The results indicate that this probiotic yoghurt was effective in alleviating some IBS symptoms and resulted in slight changes in certain gut microbiota. Probiotic yoghurt may represent a treatment for some gastrointestinal disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 243-255 |
| Number of pages | 13 |
| Journal | International Journal of Dairy Technology |
| Volume | 66 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - May 2013 |
Keywords
- DGGE
- Faecal microbiota
- IBS symptom
- Irritable bowel syndrome
- Probiotic yoghurt
Fingerprint
Dive into the research topics of 'Effects of probiotic yoghurt on symptoms and intestinal microbiota in patients with irritable bowel syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver